Telemedycyna Polska S.A. (WSE:TMP)
Poland · Delayed Price · Currency is PLN 0.3960
+0.0080 (2.06%)
At close: Sep 18, 2026
Telemedycyna Polska Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 5.49 | 5.32 | 5.44 | 6.15 | 6.49 | 5.1 | |
Revenue Growth | 0.29% | -2.25% | -11.52% | -5.24% | 27.26% | 1.73% |
Cost of Revenue | 2.62 | 2.88 | 3.26 | 2.46 | 4.13 | 2.65 |
Gross Profit | 2.88 | 2.43 | 2.18 | 3.69 | 2.36 | 2.45 |
Selling, General & Admin | 3.14 | 3.18 | 3.76 | 4.17 | 3.55 | 2.77 |
Amortization of Goodwill & Intangibles | - | - | - | - | - | 0.03 |
Other Operating Expenses | 0.25 | 0.4 | 0.4 | -0.46 | -0.32 | -0.98 |
Operating Expenses | 3.67 | 3.86 | 4.47 | 3.99 | 3.49 | 2.12 |
Operating Income | -0.79 | -1.43 | -2.29 | -0.3 | -1.14 | 0.33 |
Interest Expense | -0.03 | -0.04 | -0.07 | -0.05 | -0.15 | -0.01 |
Interest & Investment Income | - | - | 0 | 0 | 0 | - |
Other Non Operating Income (Expenses) | 0.01 | 0.01 | -0.01 | -0 | -0.02 | -0.01 |
EBT Excluding Unusual Items | -0.81 | -1.46 | -2.37 | -0.36 | -1.3 | 0.31 |
Impairment of Goodwill | -0.03 | -0.03 | -0.03 | -0.03 | -0.03 | - |
Gain (Loss) on Sale of Assets | 0 | 0 | - | 0.01 | 0 | 0 |
Asset Writedown | -0.14 | -0.14 | -0.03 | -0.03 | -0.06 | -0.11 |
Pretax Income | -0.98 | -1.62 | -2.42 | -0.41 | -1.38 | 0.19 |
Income Tax Expense | - | - | 0.28 | -0.17 | -0.01 | -0.09 |
Net Income | -0.98 | -1.62 | -2.7 | -0.23 | -1.37 | 0.29 |
Net Income to Common | -0.98 | -1.62 | -2.7 | -0.23 | -1.37 | 0.29 |
Net Income Growth | - | - | - | - | - | 0.95% |
Shares Outstanding (Basic) | 20 | 14 | 11 | 11 | 9 | 9 |
Shares Outstanding (Diluted) | 20 | 14 | 11 | 11 | 9 | 9 |
Shares Change | 86.14% | 27.16% | - | 23.04% | - | - |
EPS (Basic) | -0.05 | -0.12 | -0.25 | -0.02 | -0.16 | 0.03 |
EPS (Diluted) | -0.05 | -0.12 | -0.25 | -0.02 | -0.16 | 0.03 |
EPS Growth | - | - | - | - | - | 0.95% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -1.4 | -1.05 | -1.71 | -0.75 | -1.04 | 0.21 |
Free Cash Flow Per Share | -0.07 | -0.08 | -0.16 | -0.07 | -0.12 | 0.02 |
Gross Margin | 52.34% | 45.80% | 40.06% | 60.02% | 36.33% | 48.01% |
Operating Margin | -14.47% | -26.88% | -42.03% | -4.95% | -17.51% | 6.50% |
Profit Margin | -17.77% | -30.48% | -49.61% | -3.78% | -21.16% | 5.59% |
Free Cash Flow Margin | -25.41% | -19.77% | -31.36% | -12.13% | -16.02% | 4.12% |
EBITDA | -0.49 | -1.11 | -1.95 | 0.01 | -0.87 | 0.65 |
EBITDA Margin | -8.92% | -20.89% | -35.92% | 0.15% | -13.42% | 12.84% |
D&A For EBITDA | 0.3 | 0.32 | 0.33 | 0.31 | 0.27 | 0.32 |
EBIT | -0.79 | -1.43 | -2.29 | -0.3 | -1.14 | 0.33 |
EBIT Margin | -14.47% | -26.88% | -42.03% | -4.95% | -17.51% | 6.50% |
Revenue as Reported | 5.44 | 5.24 | 5.37 | 6.45 | 6.49 | 5.1 |